Ed Tech Tips for the 21st Century Classroom: MarketScale Mornings


No two school districts are exactly the same, but as the academic world becomes more tight-knit and ideas are exchanged more freely, children from coast to coast are beginning to feel the benefits.

Monica Burns, Founder of Class Tech Tips, LLC works with teachers and schools around the country to implement the latest technologies and methods into classrooms. She has seen firsthand how teachers are providing more engaging learning experiences for their students, and how they themselves are using technology outside of the classroom to become better teachers.

“Those levels of (technological) implementation, I think people are getting a lot more thoughtful about in the questions that they ask,” Burns said.

In recent years content, in its many forms, has become a pillar of curriculums at all stages of academia, but knowing how to use it properly is critical.

“I do want to emphasize the importance of vetting and curating here, as opposed to that instruction to ‘go out and find a podcast or go out and find a YouTube video,’. We really want to be purposeful and strategic here,” Burns said.

For more thoughts and advice from Burns, head to classtechtips.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More